NeuroDex and Stanford Publish First Blood-Based Evidence of CNS Target Engagement for GLP-1 and PPARγ Agonists

NATICK, MA, UNITED STATES, April 22, 2026 /EINPresswire.com/ -- NeuroDex and Stanford Researchers Publish First ...
News-Medical.Net

Multimodal AI improves prediction of PIK3CA mutations in breast cancer

Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway ...
EurekAlert!

Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target

Charlottesville, VA (September 23, 2014). Researchers from the University of Toronto, directed by Drs. Gelareh Zadeh and Boris Krischek, investigated gene expression in normal vestibular nerves and ...
GEN

Neuroblastoma Tumor Growth in Mice Suppressed by Blocking Enzyme to Inhibit mTOR Signaling

Neuroblastoma is the most common tumor among children under a year of age, and while in its gentlest form neuroblastoma can regress on its own, it can also take an aggressive form, with high-risk ...
ascopubs.org

Investigation of ferroptosis and mTOR signaling in chromophobe renal cell carcinoma (ChRCC).

Circulating kidney injury molecule-1 (KIM-1) in association with kidney injury biomarkers and outcomes in metastatic renal cell carcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Frontiers

Natural Bioactive Compounds and Phytochemicals in Cancer Therapy: Mechanisms of Action and Delivery Strategies

Natural products have historically served as a vital source of chemotherapeutic agents, laying the foundation for many standard-of-care drugs. However, the ...